Fundraising Fox

Gabriel Ocana Santero

Founder

Founder at Exin Therapeutics

South San Francisco, California, United States

FoundedExin Therapeutics · YC

About

Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.

Founder at Exin TherapeuticsYC W25

Intro paths

YC

Gabriel went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.

GP

Their group partner at YC was Jared Friedman, YC Group Partner — the partner who ran Exin Therapeutics's batch and knows the company first-hand. YC profile ↗

In turn, Gabriel can intro founders to Exin Therapeutics's investors below.

Co-founders at Exin Therapeutics

MTMarko Tvrdic
IA
Ivan Alex Priela LazarteExecutive Officer, Director

Experience

  1. Exin TherapeuticsCEO and Co-foundercurrent2025 — presentSan Francisco Bay Area
  2. Serotonin and BEYONDSerotonin and Beyond Early Stage Researcher2021 — 2024Oxford, England, United Kingdom
  3. Gatsby Computational Neuroscience UnitNeuroAI Research Internship2023Greater London, England, United Kingdom
  4. Fundación "la Caixa"Postgraduate Studies' Fellowship Holder2020 — 2021Oxford, England, United Kingdom
  5. Centro de Biología Molecular Severo Ochoa, CBMSOResearch Intern2020Greater Madrid Metropolitan Area
  6. Karolinska InstitutetResearch Intern2019Greater Stockholm Metropolitan Area
  7. Medical University of ViennaResearch Intern2018Austria

Skills & more

Python (Programming Language)Machine LearningArtificial Neural NetworksInvestigaciónDocenciaAptitudes de laboratorioCancer ResearchLeadership

Languages English · French · Spanish

  • The Science and Business of BiotechnologyMITx Courses
  • TOEFL-ibt (113/120)TOEFL

From Gabriel's professional profile.

Frequently asked questions

Who is Gabriel Ocana Santero?
Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.
Where does Gabriel Ocana Santero work?
Gabriel Ocana Santero is Founder of Exin Therapeutics.
What companies did Gabriel Ocana Santero found?
Gabriel Ocana Santero founded Exin Therapeutics.
Where did Gabriel Ocana Santero go to school?
Gabriel Ocana Santero studied at University of Oxford (Doctor of Philosophy - PhD, Pharmacology); Y Combinator (W25, Biotechnology); University of Oxford (Master of Science - MS, Neuroscience).

Founder mafias

Y Combinator mafia9,496

Also came through, then founded or led a company.

+ 9,489 more

Y Combinator mafia5,145

Also came through, then founded or led a company.

+ 5,138 more

University of Oxford mafia424

Also came through, then founded or led a company.

+ 417 more

Boston University mafia102

Also came through, then founded or led a company.

+ 95 more

Universidad Autónoma de Madrid mafia14

Also came through, then founded or led a company.

+ 7 more

Same school

Shared employers